medigraphic.com
Revista Médica Sinergia

2019, Number 04

<< Back Next >>

Revista Médica Sinergia 2019; 4 (04)

Hepatitis E virus infection in pregnant women

Peña MM, Barquero ODE, Molina JVN, Segura GJM

Language: Spanish
References: 24
Page: 32-40
PDF size: 251.49 Kb.


ABSTRACT

The hepatitis E virus is an emergent infectious agent that affects both developing and developed countries. This hepatotropic virus causes a wide spectrum of clinical scenarios; from an acute auto limited viral hepatitis E to a fulminant hepatic failure. Due to hormonal and immunological reasons, pregnant women are at increased risk of adverse outcomes of this disease related to higher maternal and fetal morbimortality. The main treatment for hepatitis E infections in pregnant women is merely supportive, making prevention in this population the main goal. This article will review the epidemiology, clinical scenarios and obstetric complications associated with the hepatitis virus infection during pregnancy. In addition, the progesterone and immunological system role in this disease will be discussed.


REFERENCES

  1. Teshale EH. Hepatitis E: Epidemiology and prevention. World Journal of Hepatology. 2011;3(12):285. https://doi.org/10.4254/wjh.v3.i12.285

  2. Pérez-Gracia MT, Suay-García B, Mateos-Lindemann ML. Hepatitis E and pregnancy: current state. Reviews in Medical Virology. 2017 03 20;27(3):e1929. https://doi.org/10.1002/rmv.1929

  3. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and Treatment of Hepatitis E Virus Infection. Gastroenterology. 2012 05;142(6):1388-1397.e1. https://doi.org/10.1053/j.gastro.2012.02.014

  4. Khuroo MS, Khuroo MS. Hepatitis E: an emerging global disease - from discovery towards control and cure. Journal of Viral Hepatitis. 2015 09 06;23(2):68-79. https://doi.org/10.1111/jvh.12445

  5. Teshale E, Hu D, Holmberg S. The Two Faces of Hepatitis E Virus. Clinical Infectious Diseases. 2010 08;51(3):328-334. https://doi.org/10.1086/653943

  6. Kar P, Borkakoti J, Hazam RK, Asim M, Kumar A. Does High Viral Load of Hepatitis E Virus Influence the Severity and Prognosis of Acute Liver Failure During Pregnancy?. Journal of Clinical and Experimental Hepatology. 2013 03;3(1):S2. https://doi.org/10.1016/j.jceh.2013.03.005

  7. Hakim MS, Wang W, Bramer WM, Geng J, Huang F, de Man RA, Peppelenbosch MP, Pan Q. The global burden of hepatitis E outbreaks: a systematic review. Liver International. 2016 09 09;37(1):19-31. https://doi.org/10.1111/liv.13237

  8. Aggarwal R. Clinical presentation of hepatitis E. Virus Research. 2011 Oct;161(1):15-22. https://doi.org/10.1016/j.virusres.2011.03.017

  9. Bouthry E, Benachi A, Vivanti AJ, Letamendia E, Vauloup-Fellous C, Roque-Afonso A. Autochthonous Hepatitis E during Pregnancy, France. Emerging Infectious Diseases. 2018 08;24(8):1586-1587. https://doi.org/10.3201/eid2408.180105

  10. Tabatabai J, Wenzel J, Soboletzki M, Flux C, Navid MH, Schnitzler P. First case report of an acute hepatitis E subgenotype 3c infection during pregnancy in Germany. Journal of Clinical Virology. 2014 09;61(1):170-172. https://doi.org/10.1016/j.jcv.2014.06.008

  11. Patil T, Deshpande A, Gulhane R, Bansod Y, Shinde N, Patil M. Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy. Annals of Medical and Health Sciences Research. 2014;4(8):133. https://doi.org/10.4103/2141-9248.138033

  12. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E Virus Infection. Clinical Microbiology Reviews. 2014 01 01;27(1):116-138. https://doi.org/10.1128/cmr.00057-13

  13. Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P. High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome. Journal of Hepatology. 2011 06;54(6):1107-1113. https://doi.org/10.1016/j.jhep.2010.08.037

  14. Kumar A, Devi SG, Kar P, Agarwal S, Husain SA, Gupta RK, Sharma S. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine. 2014 01;65(1):95-104. https://doi.org/10.1016/j.cyto.2013.09.022

  15. Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J. Hepatitis E Pathogenesis. Viruses. 2016 08 05;8(8):212. https://doi.org/10.3390/v8080212

  16. Kmush BL, Ali H, Engle RE, West K, Shaikh S, Christian P, Mehra S, Schulze K, Klein SL, Purcell RH, Li W, Labrique A, Wu L, Nelson K. The Association of Cytokines and Micronutrients with Hepatitis E Virus Infection During Pregnancy and the Postpartum Period in Rural Bangladesh. The American Journal of Tropical Medicine and Hygiene. 2016 01 06;94(1):203-211. https://doi.org/10.4269/ajtmh.15-0238

  17. Khuroo M, Kamali S, Jameel S. Vertical transmission of hepatitis E virus. The Lancet. 1995 04;345(8956):1025-1026. https://doi.org/10.1016/s0140-6736(95)90761-0

  18. Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. Journal of Viral Hepatitis. 2009 07;16(7):519-523. https://doi.org/10.1111/j.1365-2893.2009.01101.x

  19. Krain LJ, Labrique AB, Atwell JE, Nelson KE. Fetal and Neonatal Health Consequences of Vertically Transmitted Hepatitis E Virus Infection. The American Journal of Tropical Medicine and Hygiene. 2014 02 05;90(2):365-370. https://doi.org/10.4269/ajtmh.13-0265

  20. Rivero-Juarez A, Frias M, Rodriguez-Cano D, Cuenca-López F, Rivero A. Isolation of Hepatitis E Virus From Breast Milk During Acute Infection: Table 1.. Clinical Infectious Diseases. 2016 03 29;62(11):1464.2- 1464. https://doi.org/10.1093/cid/ciw186

  21. Chaudhry S, Verma N, Koren G. Hepatitis E infection during pregnancy. Canadian Family Physician [Internet]. 2015 [citado 22 Febrero 2019];61(7):607-608. Disponible en: http://www.cfp.ca/content/61/7/607

  22. Joshi SS, Arankalle VA. Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus. Virology Journal. 2015 05 03;12(1). https://doi.org/10.1186/s12985-015-0302-8

  23. Li S, Zhao Q, Wu T, Chen S, Zhang J, Xia N. The development of a recombinant hepatitis E vaccine HEV 239. Human Vaccines & Immunotherapeutics. 2015 02 25;11(4):908-914. https://doi.org/10.1080/21645515.2015.1008870

  24. Goel A, Aggarwal R. Advances in hepatitis E – II: Epidemiology, clinical manifestations, treatment and prevention. Expert Review of Gastroenterology & Hepatology. 2016 05 20;10(9):1065-1074. https://doi.org/10.1080/17474124.2016.1185365




2020     |     www.medigraphic.com